Santen Pharmaceutical announced that it will raise prices for 18 over-the-counter eye-care products, effective from shipments in January 2027. The increases reflect higher raw material prices and rising packaging material, energy and logistics costs. The products affected comprise 16 eye drops, including the Sante FX range, and 2 eye-washing products.
On the 13th, Santen Pharmaceutical announced that it will raise prices for 18 products, including over-the-counter eye-care products, for shipments from 1 January 2027 onward. Suggested retail prices are scheduled to increase by 5.7%–33.3%, reflecting higher raw material prices and rising packaging material, energy and logistics costs.
The products affected comprise 16 eye drops, including the Sante FX range, and 2 eye-washing products. This will be the company's first price increase. Santen Pharmaceutical explained that it had absorbed rising costs through its own efforts to date, but that maintaining the current situation had become difficult.
The price increases will apply to future shipments, with implementation expected to begin in 2027. In recognition that higher raw material and material costs are expected to continue, the company reportedly plans to review its cost structure across the business.